Fig. 2From: Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, CanadaProportion of children with and without vaccine delays at 2–4-6 and 12 month visits, 2006–2016*. *Both cohorts included. DTaP1 is recommended at 2 months, DTaP2 at 4 months, DTaP3 at 6 months and the first measles-containing vaccine at 12 monthsBack to article page